The Annals of Thoracic Surgery, Vol 42, 593-598, Copyright © 1986 by The Society of Thoracic Surgeons
Cardioplegia and calcium antagonists: a review
JW de Jong
During open-heart operations, periods occur during which the blood supply
to the heart is stopped. Myocardial damage can be limited by cooling and
induction of electromechanical arrest (cardioplegia). Many animal studies
and some clinical trials provide strong evidence for the use of calcium
antagonists, such as nifedipine, verapamil hydrochloride, diltiazem
hydrochloride, and lidoflazine, as adjuncts to cardioplegia to optimize the
protection. Salutary effects of calcium antagonists are discussed in regard
to possible mechanism of action, application time, and efficacy during
hypothermia. A major conclusion is that virtually no negative effects on
cardiac protection have as yet been described in experimental or clinical
studies, apart from short- term negative inotropic responses, while there
is an increasing body of positive evidence for their efficacy. A new
development is the use of these drugs for regional cardioplegia during
dilation of coronary arteries (transluminal angioplasty).